De-extinction startup eyes $30B valuation
Colossal Biosciences, a de-extinction startup, eyes a $30B valuation in new funding talks—doubling its worth in a year.
Category
Colossal Biosciences, a de-extinction startup, eyes a $30B valuation in new funding talks—doubling its worth in a year.